AGWCA
GILD icon

Annis Gardner Whiting Capital Advisors’s Gilead Sciences GILD Stock Holding History

Annis Gardner Whiting Capital Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$234K Sell
1,853
-165
-8% -$21.7K 0.04% 314
2026
Q1 		$281K Buy
2,018
+863
+75% +$121K 0.05% 263
2025
Q4 		$142K Buy
1,155
+612
+113% +$74.4K 0.03% 345
2025
Q3 		$60.3K Sell
543
-259
-32% -$29.4K 0.01% 465
2025
Q2 		$88.9K Buy
802
+441
+122% +$46.9K 0.03% 319
2025
Q1 		$40.5K Buy
361
+9
+3% +$929 0.02% 378
2024
Q4 		$32.5K Buy
352
+216
+159% +$19.4K 0.01% 389
2024
Q3 		$11.4K Buy
136
+39
+40% +$2.98K ﹤0.01% 533
2024
Q2 		$6.66K Buy
97
+8
+9% +$534 ﹤0.01% 738
2024
Q1 		$6.52K Sell
89
-194
-69% -$14.9K ﹤0.01% 726
2023
Q4 		$22.9K Buy
283
+93
+49% +$7.24K 0.01% 380
2023
Q3 		$14.2K Buy
+190
New +$14.6K 0.01% 431

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Annis Gardner Whiting Capital Advisors's GILD Position: Q2 2026 in Review

Annis Gardner Whiting Capital Advisors reduced its Gilead Sciences (GILD) stake by 8.2% in Q2 2026, selling an estimated $21.7K and leaving 1,853 shares worth $234K. The position accounts for 0.04% of the portfolio, ranked #314.

Annis Gardner Whiting Capital Advisors first reported a position in GILD in Q3 2023 and has held it in 12 quarters since. The position peaked at $281K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Annis Gardner Whiting Capital Advisors held 1,853 shares of Gilead Sciences worth $234K as of Q2 2026.
  • Annis Gardner Whiting Capital Advisors sold 165 Gilead Sciences shares in Q2 2026, an estimated $21.7K.
  • Gilead Sciences made up 0.04% of Annis Gardner Whiting Capital Advisors's portfolio in Q2 2026, its #314 holding.
  • Annis Gardner Whiting Capital Advisors first reported a position in Gilead Sciences in Q3 2023 and has held it in 12 quarters since.
  • Annis Gardner Whiting Capital Advisors's Gilead Sciences position peaked at $281K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.